New Strong Sell Stocks for July 22nd

Group 1: Company Overview - Belite Bio (BLTE) is focused on developing novel therapeutics for untreatable eye diseases and metabolic diseases [1] - 3D Systems (DDD) provides 3D content-to-print solutions including printers, materials, and custom parts services [2] - Annexon (ANNX) is developing therapies for classical complement-mediated disorders affecting the body, brain, and eye [3] Group 2: Earnings Estimates - Belite Bio's current year earnings estimate has been revised downward by 59.1% over the last 60 days [1] - 3D Systems' current year earnings estimate has been revised downward by 17% over the last 60 days [2] - Annexon's current year earnings estimate has been revised downward by almost 5.8% over the last 60 days [3]